Stock Comparison
KRYS vs VRTX
Krystal Biotech Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$10.97B
$124.70B
P/E (TTM)
49.8
29.2
Forward P/E
54.6
25.8
Price/Sales
26.3
10.2
Price/Book
8.6
6.4
EV/EBITDA
54.8
24.0
Dividend Yield
—
—
Profitability
Net Margin
53.90%
35.50%
Operating Margin
46.10%
38.10%
Return on Equity
19.90%
24.20%
Return on Assets
9.04%
12.10%
Growth (YoY)
Revenue Growth
31.90%
7.80%
Earnings Growth
52.50%
61.40%
Price & Risk
Beta
0.5
0.3
52-Week High
$376.28
$507.92
52-Week Low
$130.50
$362.50
Analyst Target
$349.78
$548.69
Compare KRYS and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.